Dyslexia Treatment Market Research Report Information by Type (Phonological Dyslexia, Surface Dyslexia, Others), Treatment & Diagnosis (Treatment {Medications [Antihistamines, Central Nervous Stimulant, Anti-Myoclonic, Attention-Deficit Hyperactivity Disorder (ADHD) Drug, and Others], Tools [E-Readers and Tablets, Apps, Smartpens, and Others]}, DIAGNOSIS {Paper-Based and Digital-Based}), By End Users (Specialty Center, Home Care, Hospitals & Clinics, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - F

Global Dyslexia Treatment Market Overview

The Dyslexia Treatment market is anticipated to reach USD 48.8 Billion by 2032 at 7.1% CAGR during the forecast period 2024-2032. The increasing prevalence of dyslexia and increasing app development activities to treat dyslexia are the key market drivers boosting the growth of the dyslexia treatment market.

The primary market factors fueling the growth of the dyslexia treatment market are the rising prevalence of dyslexia and the rising number of apps being developed to cure dyslexia. The market for dyslexia treatment and diagnosis is also expanding as a result of an increase in learning programs that are specifically targeted at people with the condition.

Children with dyslexia may benefit from early intervention through specialized teaching techniques. Because no two dyslexic children present with the same constellation of symptoms, researchers are working hard to find solutions to these problems. Even though there is no known cure for either disorder, drugs and CNS stimulants are routinely suggested for ADHD and dyslexia.

The market for dyslexia treatments is growing at a rapid rate due to rising consumer awareness, rising industrialization, expanding sectors, and technological advancements. In this industry, revenue and sales have grown exponentially. Due to the variables promoting the market's expansion throughout the anticipated period, both the market's size and growth are anticipated to increase.

Leading companies in the global Dyslexia Treatment market are heavily spending in R&D in order to increase their clientele and increase their market share via the reintroduction of enhanced products to customers. The study goes into detail on each company's strategy as well as their financial situation, revenue, gross margin, and growth rate.

The specific diagnostic rate is anticipated to rise because emerging economies are anticipated to become more aware of dyslexia throughout the course of the projected period. Increased efforts to develop applications to cure dyslexia are also boosting the market. Because it is anticipated that emerging economies would become more aware of dyslexia during the forecast period, it is expected that the particular diagnostic rate will increase.

August 2022, educational software provider Texthelp released the findings of a fresh study that examined how dyslexic pupils are now taught. Nearly 50% of teachers questioned indicated that using assistive technology is one of the greatest ways to help dyslexic pupils improve their literacy, along with reading and phonemic awareness, in the report from the Ireland-based company. In order to assist create better, more inclusive learning environments, the study set out to "identify common problems in student teaching and learning that could be addressed."

Dyslexia Treatment Market Trends

• Increasing prevalence of Dyslexia to Boost the Market Growth

Dyslexia is a specific learning disability that is neurobiological in origin. It is characterized by difficulties with accurate and/or fluent word recognition and by poor spelling and decoding abilities. Worldwide statistics emphasize that one in ten people will have dyslexia. Somewhere between 25-40% of children with dyslexia also have attention deficit hyperactivity disorder (ADHD) and conversely, approximately 25% of children with ADHD also have dyslexia. Similarly, according to Dystech (Australia), a science-based company publishing scientific research papers, the large patient pool suffering from dyslexia in developed nations is complemented by an increasing number of children suffering from the condition in developing countries. For instance, an article published in September 2020 in the International Journal of Environmental Research and Public Health titled “The Prevalence of Dyslexia in Primary School Children and Their Chinese Literacy Assessment in Shantou, Guangdong, China” enrolled a total of 2,955 students aged 7–12 years through randomized cluster sampling. The prevalence rate of children with dyslexia was 5.4% in Shantou, 8.4% in boys, and 2.3% in girls.

Thus, a large population suffering from learning disabilities prone to developing dyslexia is adding up a number of patients with dyslexia. Additionally, an increasing number of learning programs focused on dyslexia is helping the growth of the dyslexia treatment & diagnosis market. For example, non-profit organizations such as The African Dyslexia Organization is raising donations for “Free dyslexia diagnosis children fund” and increasing awareness about dyslexia in the region. An increase in the level of awareness in developing regions about dyslexia is expected to increase the diagnosis rate during the forecast period. The graph that follows illustrates the prevalence rate of dyslexia in males and females. The percentage of dyslexia in 3rd-grade boys and girls was 71.4% and 28.6%. Similarly, the percentages were 80.4% and 19.6%, 71.9% and 28.1%, and 75% and 25% in the 4th, 5th, and 6th grades respectively.

Figure 1: The prevalence rate of dyslexia

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Dyslexia Treatment Market Segment Insights

Dyslexia Treatment Type Insights

The dyslexia treatment market segmentation, based on type, includes phonological dyslexia, surface dyslexia, and others.

The phonological dyslexia type segment held the majority share in 2022 with respect to the dyslexia treatment market revenue. This is primarily owing to the mostly developmental (genetic/inherited), although it can also be acquired because of a stroke or Alzheimer's disease in some situations. Hence, increased incidences of phonological dyslexia have boosted the growth of this segment in the dyslexia treatment market.

February 2022:Microsoft and the Made by Dyslexia community of dyslexics collaborated to create a dyslexia training curriculum that would assist all teachers in identifying, supporting, and empowering all dyslexic students

December 2021:Intra-Cellular Therapies, Inc. announced that the US Food and Drug Administration (FDA) permitted CAPLYTA to treat depressive incidents related to bipolar I or II disorder in adults, as monotherapy and as adjunctive therapy with lithium

Dyslexia Treatment, Treatment & Diagnosis Insights

The dyslexia treatment market segmentation, based on treatment & diagnosis, includes treatment, and diagnosis. The treatment segment is further categorized into medication and tool. The treatment segment dominated the market in 2022 with respect to the dyslexia treatment market revenue. There is no particular method of treating dyslexia, but with early detection and careful evaluation, the condition of dyslexia can be improved through personalized treatment options.

Dyslexia Treatment End User Insights

The dyslexia treatment market segmentation, based on end user, includes specialty center, home care, hospitals & clinics, and others. The specialty center held the largest market share in 2022 with respect to the dyslexia treatment market revenue. Specialty center have gained demand in cases of dyslexia as it is observed that children suffering from dyslexia generally suffer from some other psychiatric disorder. Hence, the increasing number of specialty centers has boosted the growth of this segment in the dyslexia treatment market

February 2022: A new digital newsprint on Medium has been created by Understood which is a social impact non-profit organization that supports people with ADHD and dyslexia. It highlights experiences and stories that are solely from neurodivergent people

October 2022: Numerous genes have been identified by researchers as being consistently linked to dyslexia. A recent study found that around a third of the 42 genetic variations were previously connected to intelligence and educational success. The study is the largest genetic investigation of dyslexia to date and was directed by the University of Edinburgh. Using the genetic data from the study, researchers claim they were able to predict how successful adults and children from four other research studies will do at reading and spelling, but not with the precision required for diagnostic use.

Dyslexia Treatment Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. North America dyslexia treatment held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, presence of major key companies headquarters in the region such as Jubilant Cadista (US) and Speechify (US), and the high prevalence of dyslexia are driving the market in the region.

Moreover, there are several not-for-profit organizations based in the region with a presence. These organizations increase awareness regarding dyslexia and provide support to patients and their families.

Further, the major countries studied are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe dyslexia treatment market accounts for the second-largest market share due to the increasing prevalence of dyslexia rapid technological advancements, and shorter procedure time are among other factors driving the market in Europe. Further, the Germany dyslexia treatment market held the largest market share, and the UK dyslexia treatment market was the fastest-growing market in the European region.

The Asia-Pacific dyslexia treatment market is expected to grow at a significant growth rate during the forecast period. This is due to the presence of several market players and increasing disposable income. Moreover, China dyslexia treatment market held the largest market share, and the India dyslexia treatment market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period.

Dyslexia Treatment Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the dyslexia treatment market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the dyslexia treatment industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the dyslexia treatment industry to benefit clients and expand the dyslexia treatment market sector is to manufacture locally to reduce operating costs.

Lingit (Norway) is a Verdane-owned software company offering multilingual literacy support for dyslexics and others with reading and writing difficulties. The company's dyslexia aid software makes reading and writing easier by assisting with spelling, vocabulary, and reading in text processing programs for computers and tablets, enabling users with multilingual support to avoid reading and writing errors. In October 2020, Lingit AS acquired Claro Software Ltd, a UK-based software company that offers multi-platform software for reading and writing support. With this acquisition, Lingit took its first international step in the industry.

Key Companies in the Dyslexia Treatment Market Includes

• Pfizer, Inc. (US)


• Speechify Inc. (US)


• Jubilant Pharma Limited (Singapore)


• Lingit AS (Norway)


• Soli (UK)


• Novartis AG (Switzerland)


• Lyfta (UK)


• GlaxoSmithKline (UK)


• Teva Pharmaceutical Industries Ltd (Israel)


• Eli Lilly & Company (US)


• RPG Life Sciences Ltd (India)


• Hopalai D.O.O. (Slovenia)

Dyslexia Treatment Industry Developments

December 2022: The All-India Institute of Medical Sciences (AIIMS) announced the development of an app to help cure dyslexia in children. This app, being made under AIIMS Pediatric Neurology Dyslexia Remedial Intervention Program that has eight modules will allow dyslexia treatment to be done sitting at home

August 2021: An Australian ed-tech start-up named Dystech, has created a dyslexia screening tool for the early identification of learning disabilities and has raised $290K to advance the development of its Dyscover platform and make it accessible to schools and allied health professionals around the world

March 2020: Andre Agassi, unveiled a new initiative with ed-tech start-up Square Panda to develop the first-ever universally free dyslexia assessment game and an award-winning phonics learning programme that aids children from the age of two and above in the development of cognitive and reading skills

Dyslexia Treatment Market Segmentation

Dyslexia Treatment Type Outlook

• 
  

  Phonological Dyslexia

  
  


• 
  

  Surface Dyslexia

  
  


• 
  

  Others

  
  

Dyslexia Treatment, Treatment & Diagnosis Outlook

• 
  

  Treatment

  
  
  
  
  • 
    

    Medications

    
    
    
    
    • 
      

      Antihistamines

      
      
    
    
    • 
      

      Central Nervous Stimulant

      
      
    
    
    • 
      

      Anti-Myoclonic

      
      
    
    
    • 
      

      Attention-Deficit Hyperactivity Disorder (ADHD), Drug

      
      
    
    
    • 
      

      Others

      
      
    
    
    
    
  
  
  • 
    

    Tools

    
    
    
    
    • 
      

      E-readers and tablets

      
      
    
    
    • 
      

      Apps

      
      
    
    
    • 
      

      Smartpens

      
      
    
    
    • 
      

      Others

      
      
    
    
    
    
  
  
  
  


• 
  

  Diagnosis

  
  
  
  
  • 
    

    Paper-Based

    
    
  
  
  • 
    

    Digital-Based

    
    
  
  
  
  

Dyslexia Treatment End User Outlook

• 
  

  Specialty Center

  
  


• 
  

  Home Care

  
  


• 
  

  Hospitals & Clinics

  
  


• 
  

  Others

  
  

Dyslexia Treatment Regional Outlook

• 
  North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• 
  Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• 
  Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• 
  Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America